Spændende program👍🏻

Wright reduktion of 12.6 % of body weight when compared to placebo 💉 Very good new for our patients.

Published in Diabetes Care, a research journal of the ADA 🌟

Autonomic neuropathy in patients with #diabetes has long been shown to predict poor outcomes but why? In the Diabetes Care, a research journal of the ADA 🌟 study from our NSR cohort we found: Impaired autonomic function associated with ⬆️ myocardial ECV a marker of fibrosis diabetesjournals.org/care/article-a…

My bag is packed and my abstract poster presentation is ready. Chicago I can’t wait 😝 🛫🤓🥳 #AHA22 #AHA2022 #diabtes #CardioTwitter #WhyCMR Tune in to lean more about myocardial ECV and 🚬

Opening session at #AHA22 - so excited to be here. Let the show begin 🥳🤩

Great session today about disparity’s in CVD risk management in diabetes. My take home: we know that to do but we still don’t know how to do it! Especially in the lower income parts of society- were it would be most effective 😳🤥#aha22 #diabetes

Tak til @hghhjerte for det her tweet med ultrakort gennemgang af vores seneste arbejde fra NSR DM2 kohorte 🙏🏻

Yesterday the first of our 300 type 2 #diabetes patients completed the 5-year follow up #CMR. So exited to study how 5 years of diabetes have affected myocardial structure, microvascular circulation and diffuse myocardial fibrosis 👊🏻

Fantastisk præstation af Dr. Annemie Stege Bojer ved Young Investigators Award #ESCCongress 🏆 Mikrovaskulær dysfunktion i #CMR 📽️hos #T2D patienter er forbundet med GLS, selv efter justering for fibrose. Dette hjælper med at forstå hvorfor GLS er associeret med dårlig prognose🫀

A hearty round of applause to this year's winners at #ESCCongress. The path to finalising, submitting, and showcasing research demands dedication. Review the winning presentations bit.ly/3Z1OM0U Congratulations to everyone again😊 Well done!

What is the underlying pathophysiology of poor #GLS in #DM2? Myocardial microvascular dysfunction or diffuse fibrosis or perhaps both? #cmrcan rb.gy/0vfcr7